|
|
|
|
| LEADER |
01016cas a2200337 4500 |
| 001 |
PPN036368563 |
| 005 |
20141016155900.0 |
| 011 |
|
|
|a 1173-2563
|
| 035 |
|
|
|a ccn1173-2563
|
| 035 |
|
|
|z ccn7017/3923
|
| 100 |
|
|
|a 19961016a19959999||||0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a NZ
|
| 110 |
|
|
|a af|||||||||
|
| 200 |
1 |
|
|a Clinical drug investigation
|b Texte imprimé
|
| 210 |
|
|
|a Auckland
|c ADIS International
|d 1995-
|
| 430 |
|
| |
|0 039003752
|t Drug investigation
|x 0114-2402
|
| 517 |
| |
|
|a Clin. drug invest.
|
| 530 |
0 |
|
|a Clinical drug investigation
|
| 531 |
|
|
|a Clin. drug investig.
|
| 532 |
| |
| |
|a Drug investigation
|
| 676 |
|
|
|a 615.190105
|
| 712 |
0 |
2 |
|a Adis International
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20040913
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20040913
|g AFNOR
|
| 802 |
|
|
|a 0G
|
| 930 |
|
|
|5 441092101:260671908
|b 441092101
|a P1653
|j f
|
| 937 |
|
|
|a BU Santé
|c : vol. 9 no. 1 (1995) - vol. 17 no. 1 (1999)
|f Cote : P1653
|
| 955 |
4 |
1 |
|5 441092101:260671908
|a 9
|b 1
|i 1995
|a 17
|b 1
|i 1999
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 454311
|
Nantilus